CAMLINFINE103.71

Camlin Fine Sciences Limited

· Chemicals
₹ CrorePeersCLEANDEEPAKNTRBAYERCROPTIRUMALCHMATULSHKPAUSHAKLTDANURASMcap ₹1,992 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation78.673.774.0
+ Impairment Loss / (Reversal)0.0146.2-102.9
+ Finance Costs60.3100.182.1
+ Interest Income-1.20.0-3.5
+ Fair Value (Gains) / Losses-6.60.0-4.4
+ Share-based Payments0.00.02.0
+ Unrealised FX (Gain) / Loss36.625.8-21.3
+ Other Non-cash Items86.5-251.417.7
+ Other Reconciling Items0.00.059.3
Changes in Working Capital
+ Other Financial Assets — Current31.20.00.0
+ Other Current Assets0.0-71.3-21.0
+ Other Non-current Assets10.60.0-2.2
+ Other Financial Liabilities — Current0.70.00.0
+ Other Current Liabilities0.0-7.172.3
+ Other Non-current Liabilities-10.90.0-12.6
Cash from Operating Activities
Profit Before Tax (per I/S)-99.249.0-33.6-67.6
+ Total Adjustments (incl. Working Capital)285.815.9139.4
Cash from Operations (pre-tax)186.564.9105.7
+ Income Taxes Paid47.538.223.7
Cash from Operating Activities139.026.782.1
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)60.642.457.6
+ Disp of Fixed Assets0.60.00.0
+ Purchase of Investments (Equity / Debt)0.00.032.8
+ Investment in Partnership Firms / LLPs0.030.50.0
+ Dividends Received — Investing0.00.80.0
+ Interest Received — Investing1.20.93.0
+ Other Inflows / (Outflows) — Investing-7.7-4.134.5
Cash from Investing Activities-66.5-75.3-53.0
Cash from Financing Activities
+ Proceeds from Issue of Shares0.0222.90.0
+ Proceeds from Exercise of Stock Options0.60.20.5
+ Proceeds from Borrowings25.20.068.9
+ Repayment of Borrowings0.070.617.2
+ Payment of Lease Liabilities10.910.516.4
+ Interest Paid72.869.660.6
+ Other Inflows / (Outflows) — Financing-28.10.00.0
Cash from Financing Activities-86.072.4-24.6
Net Changes in Cash (pre-FX)-13.523.84.5
Net Changes in Cash-13.523.84.5
Closing Cash80.3
Reference Items
EBITDA73.9208.1106.985.9
EBITDA Margin %4.5812.496.204.61
Free Cash Flow (CFO − Capex)78.4-15.724.524.5
Free Cash Flow to Equity-97.3-13.6
Free Cash Flow per Basic Share4.08-0.821.281.28
Price to Free Cash Flow81.31
Cash Flow to Net Income-1.33-0.173.49
Cash Paid for Taxes47.538.223.7
Cash Paid for Interest72.869.660.6
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.